Fig. 4
Belimumab exhibiting significantly greater efficacy compared to placebo (MD = − 3.29, 95% CI (− 5.78 to − 0.80), P < 0.05)
Fig. 4 | Systematic Reviews
Belimumab exhibiting significantly greater efficacy compared to placebo (MD = − 3.29, 95% CI (− 5.78 to − 0.80), P < 0.05)
Systematic Reviews